EMJ would like to welcome you to the latest edition of EMJ Diabetes, a journal dedicated to detailing the vital progression in the treatment of diabetes over the last year. A comprehensive review of the key highlights from this year’s 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) is included, as well as abstract reviews of data presented at the congress, penned by the presenters themselves. Alongside world-leading peer-reviewed articles, you will also find interviews with esteemed members of the EMJ Diabetes Editorial Board.
Latest articles
All articles
11 Mins
12th
June
Nanomedicine in Diabetes Treatment: Novel Drug Delivery Systems
Diabetes is a chronic metabolic disorder characterised by persistently high blood sugar levels (hyperglycaemia) caused by deficiencies…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
25th
October
Interview: Samuel Seidu
The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with respect to the newer diabetes therapies, sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
25th
October
The Impact of Gestational Diabetes on Long-Term Kidney Disease
Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse outcomes. Recent…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.